Evidence map›Paper›PMID 33635589›Full record

ArticleAndrology2021

Severely low testosterone in males with COVID-19: A case-control study.

Andrea Salonia, Marina Pontillo, Paolo Capogrosso, Silvia Gregori, Michela Tassara, Luca Boeri, Cristina Carenzi, Costantino Abbate, Daniele Cignoli, Anna Maria Ferrara and 15 more

Open access · bronzeAbstract read
In one paragraph

Article in Andrology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 79 papers, 11 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
79citing papers in PubMed, 11 pooled it
14.8field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

79 citing papers in PubMed, 11 syntheses or guidelines pooled it, 142 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Association of the androgens with COVID-19 prognostic outcomes: a systematic review.Archives of public health = Archives belges de sante publique · 2023
    Pooled it
  6. Pooled it
  7. Pooled it
  8. Semen parameters and sex hormones as affected by SARS-CoV-2 infection: A systematic review.Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie · 2022
    Pooled it
  9. Pooled it
  10. Pooled it
  11. Urological complications of COVID-19: a systematic review.International braz j urol : official journal of the Brazilian Society of Urology
    Pooled it
  12. Article
  13. Article
  14. Testicular endocrine function recovers following Fournier's gangrene.American journal of clinical and experimental urology · 2026
    Article
  15. Article
  16. Article
  17. Article
  18. Sex Differences in Long COVID.JAMA network open · 2025
    Article
  19. Article
  20. Article

19 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

25 authors at 4 institutions in 1 country.

Andrea SaloniaDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.ORCID 0000-0002-0595-7165
Marina PontilloLaboratory Medicine Service, IRCCS Ospedale San Raffaele, Milan, Italy.
Paolo CapogrossoDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Silvia GregoriSan Raffaele Telethon Institute for Gene Therapy (SR-TIGET, IRCCS Ospedale San Raffaele, Milan, Italy.
Michela TassaraImmunohematology and Transfusion Medicine, IRRCS Ospedale San Raffaele, Milan, Italy.
Luca BoeriDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Cristina CarenziDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Costantino AbbateDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Daniele CignoliDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Anna Maria FerraraDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Walter CazzanigaDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Isaline RoweDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Giuseppe A RamirezUniversity Vita-Salute San Raffaele, Milan, Italy.
Cristina TresoldiMolecular Hematology Unit, IRCCS Ospedale San Raffaele, Milan, Italy.
Junaid MushtaqUniversity Vita-Salute San Raffaele, Milan, Italy.
Massimo LocatelliLaboratory Medicine Service, IRCCS Ospedale San Raffaele, Milan, Italy.
Luca SantoleriImmunohematology and Transfusion Medicine, IRRCS Ospedale San Raffaele, Milan, Italy.
Antonella CastagnaUniversity Vita-Salute San Raffaele, Milan, Italy.
Alberto ZangrilloUniversity Vita-Salute San Raffaele, Milan, Italy.
Francesco De CobelliUniversity Vita-Salute San Raffaele, Milan, Italy.
Moreno TresoldiGeneral Medicine and Advanced Care Unit, IRCCS Ospedale San Raffaele, Milan, Italy.
Giovanni LandoniUniversity Vita-Salute San Raffaele, Milan, Italy.
Patrizia Rovere-QueriniUniversity Vita-Salute San Raffaele, Milan, Italy.
Fabio CiceriUniversity Vita-Salute San Raffaele, Milan, Italy.
Francesco MontorsiDivision of Experimental Oncology/Unit of Urology, URI, IRCCS Ospedale San Raffaele, Milan, Italy.
Vita-Salute San Raffaele University · ITIRCCS Ospedale San Raffaele · ITOspedale di Circolo e Fondazione Macchi · ITUniversity of Milan · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundCirculating androgens could have a relevant pathobiological role in clinical outcomes in men with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection (COVID-19).

objectivesWe aimed to assess: (a) circulating sex steroids levels in a cohort of 286 symptomatic men with laboratory-confirmed COVID-19 at hospital admission compared to a cohort of 281 healthy men; and (b) the association between serum testosterone levels (tT), COVID-19, and clinical outcomes. MATERIALS AND

methodsDemographic, clinical, and hormonal values were collected for all patients. Hypogonadism was defined as tT ≤9.2 nmol/l. The Charlson Comorbidity Index (CCI) was used to score health-significant comorbidities. Severe clinical outcomes were defined as patients either transferred to intensive care unit (ICU) or death. Descriptive statistics and multivariable linear and logistic regression models tested the association between clinical and laboratory variables and tT levels. Univariable and multivariable logistic regression models tested the association between tT and severe clinical outcomes.

resultsOverall, a significantly lower levels of LH and tT were found in patients with COVID-19 compared to healthy controls (all p < 0.0001); conversely, healthy controls depicted lower values of circulating E

conclusionsWe unveil an independent association between SARS-CoV-2 infection status and secondary hypogonadism already at hospital admission, with lower testosterone levels predicting the most severe clinical outcomes.

Indexed as

AdultAgedBiomarkersCase-Control StudiesCohort StudiesCOVID-19Gonadal Steroid HormonesHumansHypogonadismMaleMiddle AgedTestosteroneTreatment OutcomeBiomarkersGonadal Steroid HormonesTestosteroneCOVID-19maleSARS-CoV-2testosterone

Identifiers

PMID33635589
PMCPMC8013327
OpenAlexW3129628453

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.